Zobrazit více v PubMed
Scosyrev E., Noyes K., Feng C., Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2009;115:68–74. doi: 10.1002/cncr.23986.
PubMed
DOI
Radkiewicz C., Edgren G., Johansson A.L.V., Jahnson S., Häggström C., Akre O., Lambe M., Dickman P.W. Sex Differences in Urothelial Bladder Cancer Survival. Clin. Genitourin. Cancer. 2020;18:26–34. doi: 10.1016/j.clgc.2019.10.020.
PubMed
DOI
Nakayama M., Ito Y., Hatano K., Nakai Y., Kakimoto K., Miyashiro I., Nishimura K. Impact of sex difference on survival of bladder cancer: A population-based registry data in Japan. Int. J. Urol. 2019;26:649–654. doi: 10.1111/iju.13955.
PubMed
DOI
Kluth L.A., Rieken M., Xylinas E., Kent M., Rink M., Rouprêt M., Sharifi N., Jamzadeh A., Kassouf W., Kaushik D., et al. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: An international multi-institutional study of more than 8000 patients. Eur Urol. 2014;66:913. doi: 10.1016/j.eururo.2013.11.040.
PubMed
DOI
Otto W., May M., Fritsche H.-M., Dragun D., Aziz A., Gierth M., Trojan L., Herrmann E., Moritz R., Ellinger J., et al. Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: Results of a large german multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend. Med. 2012;9:481–489. doi: 10.1016/j.genm.2012.11.001.
PubMed
DOI
Tufano A., Cordua N., Nardone V., Ranavolo R., Flammia R.S., D’Antonio F., Borea F., Anceschi U., Leonardo C., Morrione A., et al. Prognostic Significance of Organ-Specific Metastases in Patients with Metastatic Upper Tract Urothelial Carcinoma. J. Clin. Med. 2022;11:5310. doi: 10.3390/jcm11185310.
PubMed
DOI
PMC
Messer J.C., Shariat S.F., Dinney C.P., Novara G., Fradet Y., Kassouf W., Karakiewicz P.I., Fritsche H.-M., Izawa J.I., Lotan Y., et al. Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: A competing risk analysis. Urology. 2014;83:863–868. doi: 10.1016/j.urology.2013.10.060.
PubMed
DOI
Rosiello G., Palumbo C., Pecoraro A., Luzzago S., Deuker M., Stolzenbach L.F., Tian Z., Gallina A., Gandaglia G., Montorsi F., et al. The effect of sex on disease stage and survival after radical cystectomy: A population-based analysis. Urol. Oncol. Semin. Orig. Investig. 2021;39:e1–e236. doi: 10.1016/j.urolonc.2020.09.004.
PubMed
DOI
Uhlig A., Hosseini A.S.A., Simon J., Lotz J., Trojan L., Schmid M., Uhlig J. Gender Specific Differences in Disease-Free, Cancer Specific and Overall Survival after Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. J. Urol. 2018;200:48–60. doi: 10.1016/j.juro.2017.11.150.
PubMed
DOI
Humphrey P.A., Moch H., Cubilla A.L., Ulbright T.M., Reuter V.E. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours. Eur. Urol. 2016;70:106–119. doi: 10.1016/j.eururo.2016.02.028.
PubMed
DOI
Flammia R.S., Chierigo F., Würnschimmel C., Wenzel M., Horlemann B., Tian Z., Borghesi M., Leonardo C., Tilki D., Shariat S.F., et al. Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer. Cent. Eur. J. Urol. 2022;75:240–247. doi: 10.5173/ceju.2022.0053.
PubMed
DOI
PMC
Deuker M., Martin T., Stolzenbach F., Rosiello G., Collà Ruvolo C., Karakiewicz P.I. Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities. Clin. Genitourin. Cancer. 2021;19:60–68.e1. doi: 10.1016/j.clgc.2020.07.011.
PubMed
DOI
Flaig T.W., Spiess P.E., Agarwal N., Bangs R., Boorjian S.A., Buyyounouski M.K., Chang S., Downs T.M., Efstathiou J.A., Friedlander T., et al. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr Cancer Netw. 2020;18:329–354. doi: 10.6004/jnccn.2020.0011.
PubMed
DOI
Pottegård A., Kristensen K.B., Friis S., Hallas J., Jensen J.B., Nørgaard M. Urinary tract infections and risk of squamous cell carcinoma bladder cancer: A Danish nationwide case-control study. Int. J. Cancer. 2020;146:1930–1936. doi: 10.1002/ijc.32842.
PubMed
DOI
Noon A., Albertsen P.C., Thomas F., Rosario D.J., Catto J.W.F. Competing mortality in patients diagnosed with bladder cancer: Evidence of undertreatment in the elderly and female patients. Br. J. Cancer. 2013;108:1534–1540. doi: 10.1038/bjc.2013.106.
PubMed
DOI
PMC
Månsson Å., Anderson H., Colleen S. Time lag to diagnosis of bladder cancer-influence of psychosocial parameters and level of health-care provision. Scand. J. Urol. Nephrol. 1993;27:363–369. doi: 10.3109/00365599309180448.
PubMed
DOI
Ark J.T., Alvarez J.R., Koyama T., Bassett J.C., Blot W.J., Mumma M.T., Resnick M.J., You C., Penson D., Barocas D.A. Variation in the Diagnostic Evaluation among Persons with Hematuria: Influence of Gender, Race and Risk Factors for Bladder Cancer. J. Urol. 2017;198:1033–1038. doi: 10.1016/j.juro.2017.06.083.
PubMed
DOI
PMC
Cohn J.A., Vekhter B., Lyttle C., Steinberg G.D., Large M.C. Sex disparities in diagnosis of bladder cancer after initial resentation with hematuria: A nationwide claims-based investigation. Cancer. 2014;120:555–561. doi: 10.1002/cncr.28416.
PubMed
DOI
PMC
Santos F., Dragomir A., Kassouf W., Franco E., Aprikian A. Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer. Curr. Oncol. 2015;22:20–26. doi: 10.3747/co.22.2052.
PubMed
DOI
PMC
Barocas D.A., Boorjian S.A., Alvarez R.D., Downs T.M., Gross C.P., Hamilton B.D., Kobashi K.C., Lipman R.R., Lotan Y., Ng C.K., et al. Microhematuria: AUA/SUFU Guideline. J. Urol. 2020;204:778–786. doi: 10.1097/JU.0000000000001297.
PubMed
DOI
Woldu S.L., Ng C.K., Loo R.K., Slezak J.M., Jacobsen S.J., Tan W.S., Kelly J.D., Lough T., Darling D., van Kessel K.E.M., et al. Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria. J. Urol. 2021;205:1387–1393. doi: 10.1097/JU.0000000000001550.
PubMed
DOI
Mir C., Shariat S.F., Van der Kwast T., Ashfaq R., Lotan Y., Evans A., Skeldon S., Hanna S., Vajpeyi R., Kuk C., et al. Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: A large multi-institutional study. BJU Int. 2011;108:24–30. doi: 10.1111/j.1464-410X.2010.09834.x.
PubMed
DOI
Del Giudice F., Busetto G.M., Gross M.S., Maggi M., Sciarra A., Salciccia S., Ferro M., Sperduti I., Flammia S., Canale V., et al. Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: Results from a retrospective single-institution cohort analysis. J. Cancer Res. Clin. Oncol. 2021;147:3073–3080. doi: 10.1007/s00432-021-03571-0.
PubMed
DOI
PMC
Sorce G., Chierigo F., Flammia R.S., Hoeh B., Hohenhorst L., Tian Z., Goyal J.A., Graefen M., Terrone C., Gallucci M., et al. Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity. Urol. Oncol. 2022;40:e19–e380. doi: 10.1016/j.urolonc.2022.03.014.
PubMed
DOI
Flammia R.S., Chierigo F., Würnschimmel C., Horlemann B., Gallucci M., Karakiewicz P.I. Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma. Urol. Oncol. 2022;40:165.e9–165.e15. doi: 10.1016/j.urolonc.2021.09.008.
PubMed
DOI
Sorce G., Flammia R.S., Hoeh B., Chierigo F., Briganti A., Karakiewicz P.I. Plasmacytoid variant urothelial carcinoma of the bladder: Effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients. World J. Urol. 2022;40:1481–1488. doi: 10.1007/s00345-022-03940-5.
PubMed
DOI